Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Gershman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
MMWR. Morbidity and Mortality Weekly Report|July 28, 2017
Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril VaccineMark D Gershman, Mark J Sotir
The American Journal of Tropical Medicine and Hygiene|February 3, 2021
Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018Allison Taylor Walker, Mark D Gershman, Sowmya R Rao, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2017
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017Mark D Gershman, Kristina M Angelo, Julian Ritchey, et al.
The American Journal of Tropical Medicine and Hygiene|March 6, 2013
Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011Emily S Jentes, Pauline Han, Mark D Gershman, et al.
JAMA Internal Medicine|June 3, 2014
Health and safety issues for travelers attending the World Cup and Summer Olympic and Paralympic Games in Brazil, 2014 to 2016Joanna Gaines, Mark J Sotir, Timothy J Cunningham, et al.
The Lancet. Infectious Diseases|July 30, 2011
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow FeverEmily S Jentes, Gilles Poumerol, Mark D Gershman, et al.
The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNetBhushan R Deshpande, Sowmya R Rao, Emily S Jentes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacyMark D Gershman, Donald J Kennedy, Judith Noble-Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
MMWR. Morbidity and Mortality Weekly Report|July 28, 2017
Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril VaccineMark D Gershman, Mark J Sotir
The American Journal of Tropical Medicine and Hygiene|February 3, 2021
Yellow Fever Vaccine Administration at Global TravEpiNet (GTEN) Clinics during a Period of Limited Vaccine Availability in the United States, 2017-2018Allison Taylor Walker, Mark D Gershman, Sowmya R Rao, et al.
MMWR. Morbidity and Mortality Weekly Report|May 5, 2017
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017Mark D Gershman, Kristina M Angelo, Julian Ritchey, et al.
The American Journal of Tropical Medicine and Hygiene|March 6, 2013
Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011Emily S Jentes, Pauline Han, Mark D Gershman, et al.
JAMA Internal Medicine|June 3, 2014
Health and safety issues for travelers attending the World Cup and Summer Olympic and Paralympic Games in Brazil, 2014 to 2016Joanna Gaines, Mark J Sotir, Timothy J Cunningham, et al.
The Lancet. Infectious Diseases|July 30, 2011
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow FeverEmily S Jentes, Gilles Poumerol, Mark D Gershman, et al.
The American Journal of Tropical Medicine and Hygiene|July 30, 2014
Use of Japanese encephalitis vaccine in US travel medicine practices in Global TravEpiNetBhushan R Deshpande, Sowmya R Rao, Emily S Jentes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacyMark D Gershman, Donald J Kennedy, Judith Noble-Wang, et al.
Pageof 1